Macular pigment and lutein supplementation in ABCA4-associated retinal degenerations

Investigative Ophthalmology and Visual Science

Volumn 48, Issue 3, 2007, Pages 1319-1329

  Aleman, Tomas S ^a   Cideciyan, Artur V ^a   Windsor, Elizabeth A M ^a   Schwartz, Sharon B ^a   Swider, Malgorzata ^a   Chico, John D ^a   Sumaroka, Alexander ^a   Pantelyat, Alexander Y ^a   Duncan, Keith G ^b   Gardner, Leigh M ^a   Emmons, Jessica M ^a   Steinberg, Janet D ^a   Stone, Edwin M ^c   Jacobson, Samuel G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; VISUAL PIGMENT; XANTHOPHYLL; ZEAXANTHIN; ABC TRANSPORTER; ABCA4 PROTEIN, HUMAN; UNCLASSIFIED DRUG;

ABCA4 GENE; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GENE; GENE MUTATION; HUMAN; MALE; OPEN STUDY; OPTICAL DENSITY; PHOTOMETRY; PILOT STUDY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RETINA; RETINA CONE; RETINA DEGENERATION; RETINA DYSTROPHY; RETINA FOVEA; RETINA ROD; STARGARDT DISEASE; THICKNESS; TISSUE LEVEL; TREATMENT RESPONSE; VISION; VISUAL ACUITY; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; ADOLESCENT; BLOOD; DRUG EFFECT; GENETICS; METABOLISM; MIDDLE AGED; OPTICAL COHERENCE TOMOGRAPHY; ORAL DRUG ADMINISTRATION; PATHOLOGY;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ATP-BINDING CASSETTE TRANSPORTERS; BETA CAROTENE; FEMALE; HUMANS; LUTEIN; MALE; MIDDLE AGED; PHOTOMETRY; PILOT PROJECTS; RETINA; RETINAL DEGENERATION; RETINAL PIGMENTS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY; XANTHOPHYLLS;

EID: 34047265492     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0764     Document Type: Article

References (91)

1. Papermaster DS, Reilly P, Schneider BG. Cone lamellae and red and green rod outer segment disks contain a large intrinsic membrane protein on their margins: an ultrastructural immunocytochemical study of frog retinas. Vision Res. 1982;22:1417-1428.
2. Molday LL, Rabin AR, Molday RS. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet. 2000;25:257-258.
3. Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH. Insights into the function of rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in ABCR knockout mice. Cell. 1999;98:13-23.
4. Sun H, Molday RS, Nathans J. Retinal stimulates ATP hydrolysis by purified and reconstituted ABCR, the photoreceptor-specific ATP-binding cassette transporter responsible for Stargardt disease. J Biol Chem. 1999;274:8269-8281.
5. Beharry S, Zhong M, Molday RS. N-retinylidene-phosphatidylethanolamine is the preferred retinoid substrate for the photoreceptor-specific ABC transporter ABCA4 (ABCR). J Biol Chem. 2004; 279:53972-53979.
6. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15:236-246.
7. Martinez-Mir A, Paloma E, Allikmets R, et al. Retinitis pigmentosa caused by a homozygous mutation in the Stargardt disease gene ABCR. Nat Genet. 1998;18:11-12.
8. Cremers FPM, van de Pol DJR, van Driel M, et al. Autosomal recessive retinitis pigmentosa and cone-rod dystrophy caused by splice site mutations in the Stargardt's disease gene ABCR. Hum Mol Genet. 1998;7:355-362.
9. Fishman GA, Stone EM, Grover S, Derlacki DJ, Haines HL, Hockney RR. Variation of clinical expression in patients with Stargardt dystrophy and sequence variations in the ABCR gene. Arch Ophthalmol. 1999;117:504-510.
10. Fishman GA, Stone EM, Eliason DA, Taylor CM, Lindeman M, Derlacki DJ. ABCA4 gene sequence variations in patients with autosomal recessive cone-rod dystrophy. Arch Ophthalmol. 2003; 121:851-855.
11. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525-534.
12. Cideciyan AV, Swider M, Aleman TS, et al. ABCA4-associated retinal degenerations spare structure and function of the human parapapillary retina. Invest Ophthalmol Vis Sci. 2005;46:4739-4746.
13. Sparrow JR, Fishkin N, Zhou J, et al. A2E, a byproduct of the visual cycle. Vision Res. 2003;43:2983-2990.
14. Bergmann M, Schutt F, Holz FG, Kopitz J. Inhibition of the ATP-driven proton pump in RPE lysosomes by the major lipofuscin fluorophore A2-E may contribute to the pathogenesis of age-related macular degeneration. FASEB J. 2004;18:562-564.
15. Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci USA. 2000;97:7154-7259.
16. Pinckers A, Cruysberg JR, aan de Kerk AL. Main types of bull's eye maculopathy. Functional classification. Doc Ophthalmol. 1984;58: 257-267.
17. Wajima R, Katsumi O, Mehta MC, Itabashi R, Hirose T. Pattern-reversal visual-evoked response in bull's eye maculopathy associated with Stargardt's disease. Ophthalmic Res. 1995;27:234-242.
18. Kurz-Levin MM, Halfyard AS, Bunce C, Bird AC, Holder GE. Clinical variations in assessment of bull's-eye maculopathy. Arch Ophthalmol. 2002;120:567-575.
19. Weiter JJ, Delori F, Dorey CK. Central sparing in annular macular degeneration. Am J Ophthalmol. 1988;106:286-292.
20. Landrum JT, Bone RA, Kilburn MD. The macular pigment: a possible role in protection from age-related macular degeneration. Adv Pharmacol. 1997;38:537-556.
21. Hammond BR Jr, Wooten BR, Snodderly DM. Preservation of visual sensitivity of older subjects: association with macular pigment density. Invest Ophthalmol Vis Sci. 1998;39:397-406.
22. Snodderly DM, Hammond BR Jr. In vivo psychophysical assessment of nutritional and environmental influences on human ocular tissues: lens and macular pigment. In: Taylor A, ed. Nutritional and Environmental Influences on the Eye. Boca Raton, FL: CRC Press; 1999:251-273.
23. Junghans A, Sies H, Stahl W. Macular pigments lutein and zeaxanthin as blue light filters studied in liposomes. Arch Biochem Biophys. 2001;391:160-164.
24. Thomson LR, Toyoda Y, Langner A, et al. Elevated retinal zeaxanthin and prevention of light-induced photoreceptor cell death in quail. Invest Ophthalmol Vis Sci. 2002;43:3538-3549.
25. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003;23:171-201.
26. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal pathobiology. Exp Eye Res. 2005;80:595-606.
27. Roberts JE, Kukielczak BM, Hu DN, et al. The role of A2E in prevention or enhancement of light damage in human retinal pigment epithelial cells. Photochem. Photobiol. 2002;75:184-190.
28. Kim SR, Nakanishi K, Itagaki Y, Sparrow JR. Photooxidation of A2-PE, a photoreceptor outer segment fluorophore, and protection by lutein and zeaxanthin. Exp Eye Res. 2006;82:828-839.
29. Webster AR, Heon E, Lotery AJ, et al. An analysis of allelic variation in the ABCA4 gene. Invest Ophthalmol Vis Sci. 2001;42:1179-1189.
30. Aleman TS, Duncan JL, Bieber ML, et al. Macular pigment and lutein supplementation in retinitis pigmentosa and Usher syndrome. Invest Ophthalmol Vis Sci. 2001;42:1873-1881.
31. Wooten BR, Hammond BR, Land RI, Snodderly DM. A practical method for measuring macular pigment optical density. Invest Ophthalmol Vis Sci. 1999;40:2481-2489.
32. Duncan JL, Aleman TS, Gardner LM, et al. Macular pigment and lutein supplementation in choroideremia. Exp Eye Res. 2002;74: 371-381.
33. Werner JS, Donnelly SK, Kliegl R. Aging and human macular pigment density: appended with translations from the work of Max Schultz and Ewald Hering. Vision Res. 1987;27:257-268.
34. Bone RA, Landrum JT, Gilbert J. Macular pigment and the edge hypothesis of flicker photometry. Vision Res. 2004;44:3045-3051.
35. Jacobson SG, Voigt WJ, Parel JM, et al. Automated light- and dark-adapted perimetry for evaluating retinitis pigmentosa. Ophthalmology. 1986;93:1604-1611.
36. Hee MR, Izatt JA, Swanson EA, et al. Optical coherence tomography of the human retina. Arch Ophthalmol. 1995;113:325-332.
37. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA. 2005;102: 6177-6182.
38. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol. 1986;124:453-469.
39. Block G, Coyle LM, Hartman AM, Scoppa SM. Revision of dietary analysis software for the Health Habits and History Questionnaire. Am J Epidemiol. 1994;139:1190-1196.
40. Khachik F, Beecher GR, Smith JC Jr. Lutein, lycopene, and their oxidative metabolites in chemoprevention of cancer. J Cell Biochem. 1995;22:236-246.
41. Hammond BR Jr, Wooten BR, Snodderly DM. Individual variations in the spatial profile of human macular pigment. J Opt Soc Am A. 1997;14:1187-1196.
42. Delori FC, Goger DG, Keilhauer C, Salvetti P, Staurenghi G. Bimodal spatial distribution of macular pigment: evidence of a gender relationship. J Opt Soc Am A. 2006;23:521-538.
43. Schalch W, Dayhaw-Barker P, Barker FM II. The carotenoids of the human retina. In: Taylor A, ed. Nutritional and Environmental Influences on the Eye. Boca Raton: CRC Press;1999:215-250.
44. Johnson EJ, Hammond BR, Yeum K-J, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555-1562.
45. Nolan J, O'donovan O, Kavanagh H, Stack J, Harrison M, Muldoon A, Mellerio J, Beatty S. Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci. 2004;45:3940-3950.
46. Hammond BR Jr, Curran-Celentano J, Judd S, et al. Sex differences in macular pigment optical density: relation to plasma carotenoid concentrations and dietary patterns. Vision Res. 1996;36:2001-2012.
47. Snodderly DM, Mares JA, Wooten BR, Oxton L, Gruber M, Ficek T; CAREDS Macular Pigment Study Group. Macular pigment measurement by heterochromatic flicker photometry in older subjects: the carotenoids and age-related eye disease study. Invest Ophthalmol Vis Sci. 2004;45:531-538.
48. Ciulla TA, Hammond BR Jr. Macular pigment density and aging, assessed in the normal elderly and those with cataracts and age-related macular degeneration. Am J Ophthalmol. 2004;138:582-587.
49. Hammond BR Jr, Wooten BR, Snodderly DM. Cigarette smoking and retinal carotenoids: implications for age-related macular degeneration. Vision Res. 1996;36:3003-3009.
50. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas, III: effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci. 2005;46:692-702.
51. Broekmans WMR, Berendschot TTJM, Klöpping-Ketelaars IAA, et al. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr. 2002;76:595-603.
52. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133: 992-998.
53. Beatty S, Nolan J, Kavanagh H, O'Donovan O. Macular pigment optical density and its relationship with serum and dietary levels of lutein and zeaxanthin. Arch Biochem Biophys. 2004;430:70-76.
54. Hammond BR Jr, Fuld K, Snodderly DM. Iris color and macular pigment optical density. Exp Eye Res. 1996;62:293-297.
55. Ford ES. Variations in serum carotenoid concentrations among United States adults by ethnicity and sex. Ethn Dis. 2000;10:208-217.
56. Curran-Celentano J, Hammond BR Jr, Ciulla TA, Cooper DA, Pratt LM, Danis RB. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr. 2001;74:796-802.
57. Mares-Perlman JA, Brady WE, Klein R, et al. Serum antioxidants and age-related macular degeneration in a population-based case-control study. Arch Ophthalmol. 1995;113:1518-1523.
58. Gruber M, Chappell R, Millen A, et al. Correlates of serum lutein + zeaxanthin: findings from the third national health and nutrition examination survey. J Nutr. 2004;134:2387-2394.
59. Liew SH, Gilbert CE, Spector TD, et al. Central retinal thickness is positively correlated with macular pigment optical density. Exp Eye Res. 2006;82:915-920.
60. Hammond BR Jr, Fuld K. Interocular differences in macular pigment density. Invest Ophthalmol Vis Sci. 1992;33:350-355.
61. Koh HH, Murray IJ, Nolan D, Carden D, Feather J, Beatty S. Plasma and macular responses to lutein supplement in subjects with and without age-related maculopathy: a pilot study. Exp Eye Res. 2004; 79:21-27.
62. Nolan JM, Stack J, Mellerio J, et al. Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res. 2006;31:199-213.
63. Hammond BRJr, Johnson EJ, Russell RM, et al. Dietary modification of human macular pigment density. Invest Ophthalmol Vis Sci. 1997;38:1795-1801.
64. Davies NP, Morland AB. Macular pigments: their characteristics and putative role. Prog Retin Eye Res. 2004;23:533-559.
65. Malinow MR, Feeney-Burns L, Peterson LH, Klein ML, Neuringer M. Diet-related macular anomalies in monkeys. Invest Ophthalmol Vis Sci. 1980;19:857-863.
66. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Snodderly DM. Nutritional manipulation of primate retinas, H: effects of age, n-3 fatty acids, lutein, and zeaxanthin on retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2004;45:3244-3256.
67. Leung IY, Sandstrom MM, Zucker CL, Neuringer M, Max Snodderly D. Nutritional manipulation of primate retinas. IV. Effects of n-3 fatty acids, lutein, and zeaxanthin on S-cones and rods in the foveal region. Exp Eye Res. 2005;81:513-529.
68. Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye Disease Case-Control Study Group. JAMA. 1994;272: 1413-1420.
69. Beatty S, Boulton M, Henson D, Koh H-H, Murray IJ. Macular pigment and age related macular degeneration. Br J Ophthalmol. 1999;83:867-877.
70. Zhang X, Hargitai J, Tammur J, et al. Macular pigment and visual acuity in Stargardt macular dystrophy. Graefes Arch Clin Exp Ophthalmol. 2002;240:802-809.
71. Zhao D-Y, Wintch SW, Ermakov IV, Gellermann W, Bernstein PS. Resonance Raman measurement of macular carotenoids in retinal, choroidal, and macular dystrophies. Arch Ophthalmol. 2003;121: 967-972.
72. Snodderly DM, Auran JD, Delori FC. The macular pigment. II: spatial distribution in primate retinas. Invest Ophthalmol Vis Sci. 1984;25:674-685.
73. Cense B, Chen TC, Park BH, Pierce MC, de Boer JF. Thickness and birefringence of healthy retinal nerve fiber layer tissue measured with polarization-sensitive optical coherence tomography. Invest Ophthalmol Vis Sci. 2004;45:2606-2612.
74. Hammond BR Jr, Wooten BR, Smollon B. Assessment of the validity of in vivo methods of measuring human macular pigment optical density. Optom Vis Sci. 2005;82:387-404.
75. Kilbride PE, Alexander KR, Fishman M, Fishman GA. Human macular pigment assessed by imaging fundus reflectometry. Vision Res. 1989;29:663-674.
76. Delori FC, Goger DG, Hammond BR, Snodderly DM, Burns SA. Macular pigment density measured by autofluorescence spectrometry: comparison with reflectometry and heterochromatic flicker photometry. J Opt Soc Am A. 2001;18:1212-1230.
77. Bernstein PS, Yoshida MD, Katz NB, McClane RW, Gellermann W. Raman detection of macular carotenoid pigments in intact human retina. Invest Ophthalmol Vis Sci. 1998;39:2003-2011.
78. Moreland JD, Robson AG, Soto-Leon N, Kulikowski JJ. Macular pigment and the colour-specificity of visual evoked potentials. Vision Res. 1998;38:3241-3245.
79. Davies NP, Morland AB. Color matching in diabetes: optical density of the crystalline lens and macular pigments. Invest Ophthalmol Vis Sci. 2002;43:281-289.
80. Werner JS, Bieber ML, Schefrin BE. Senescence of foveal and parafoveal cone sensitivities and their relations to macular pigment density. J Opt Soc Am A. 2000;17:1918-1932.
81. Morse PH, Smith VC, Pokorny JM, Burch JV. Fundus flavimaculatus with cystoid macular changes and abnormal Stiles-Crawford effect. Am J Ophthalmol. 1981;91:190-196.
82. van Meel GJ, van Norren D. Foveal densitometry as a diagnostic technique in Stargardt's disease. Am J Ophthalmol. 1986;102:353-362.
83. Kilbride PE, Fishman M, Fishman GA, Hutman LP. Foveal cone pigment density difference and reflectance in retinitis pigmentosa. Arch Ophthalmol. 1986;104:220-224.
84. Eisner AE, Burns SA, Weiter JJ. Cone photopigment in older subjects: decreased optical density in early age-related macular degeneration. J Opt Soc Am A. 2002;19:215-222.
85. Kostic D, White WS, Olson JA. Intestinal absorption, serum clearance, and interactions between lutein and β-carotene when administered to human adults in separate or combined oral doses. Am J Clin Nutr. 1995;62:604-610.
86. Anderson RE, Maude MB, Alvarez RA, Acland G, Aguirre GD. A hypothesis to explain the reduced blood levels of docosahexaenoic acid in inherited retinal degenerations caused by mutations in genes encoding retina-specific proteins. Lipids. 1999;34(suppl)S235-S237.
87. Dagnelie G, Zorge IS, McDonald TM. Lutein improves visual function in some patients with retinal degeneration: a pilot study via the Internet. Optometry. 2000;71:147-164.
88. Bahrami H, Melia M, Dagnelie G. Lutein supplementation in retinitis pigmentosa: PC-based vision assessment in a randomized double-masked placebo-controlled clinical trial. BMC Ophthalmol. 2006;6:23.
89. Hininger IA, Meyer-Wenger A, Moser U, et al. No significant effects of lutein, lycopene or beta-carotene supplementation on biological markers of oxidative stress and LDL oxidizability in healthy adult subjects. J Am Coll Nutr. 2001;20:232-238.
90. Landrum JT, Bone RA, Joa H, Kilburn MD, Moore LL, Sprague KE. A one year study of the macular pigment: the effect of 140 days of a lutein supplement. Exp Eye Res. 1997;65:57-62.
91. Rapp LM, Maple SS, Choi JH. Lutein and zeaxanthin concentrations in rod outer segment membranes from perifoveal and peripheral human retina. Invest Ophthalmol Vis Sci. 2000;41:1200-1209.